LFCR
Lifecore Biomedical Inc.
4.40$
-2.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.7% | +34.6% | -32.6% | -19.0% | -206.4% | – | -248.1% | – | – | -180.2% | – | |
| – | +32.5% | +13.6% | +16.2% | +22.7% | +23.7% | +5.5% | -10.0% | +1.0% | -56.0% | +0.9% | -15.2% | |
| – | +119.7% | +14.4% | +11.1% | -19.1% | -99.9% | +141,373.7% | -22.4% | +0.0% | +137.8% | +63.8% | -39.2% | |
| – | – | – | – | – | +1,400.3% | -36.3% | +226.3% | -47.9% | – | – | – | |
| – | -177.6% | – | -1,828.6% | – | – | – | -167.6% | – | – | – | – | |
| – | +133.4% | -44.7% | +48.7% | +33.2% | -40.3% | -5.5% | +11.5% | +6.4% | -38.6% | -27.1% | -52.8% | |
| – | +20.8% | -39.9% | +42.3% | +172.0% | -75.3% | -48.5% | – | -2.2% | -123.0% | -65.1% | -74.6% | |
| – | – | – | – | – | -69.7% | – | – | – | +1,023.4% | – | – | |
| – | – | – | +240.6% | -52.6% | -69.7% | +91.0% | – | – | -80.7% | – | – | |
| – | – | – | – | – | -47.7% | -82.1% | -841.8% | – | -88.8% | -825.1% | – | |
| – | +90.6% | -156.5% | – | +494.5% | -49.4% | -108.5% | +1,567.8% | +0.0% | – | -14.4% | -117.2% | |
| – | – | – | – | – | – | – | -53.1% | +0.0% | -3,154.3% | – | – | |
| – | -320.8% | – | -305.1% | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.